ENTITY
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals (REGN US)

129
Analysis
Health Care • United States
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.
more
Company Event • 30 Oct 2026 20:30 • Upcoming
Add To Calendar

Q3 2026

Company Event • 23 Sep 2026 22:30 • Latest

Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum

Company Event • 15 Sep 2026 01:05

Morgan Stanley 24th Annual Global Healthcare Conference

Company Event • 12 Jun 2026 22:30

AGM 2026

Company Event • 09 Jun 2026 02:00

Goldman Sachs 47th Annual Global Healthcare Conference 2026

x